MedPath

Intervention study to verify the effect of the changes in intestinal bacteria by intake of tea catechin and inulin on visceral fat reductio

Not Applicable
Recruiting
Conditions
Visceral fat obese
Registration Number
JPRN-jRCTs021230004
Lead Sponsor
Mikami Tatsuya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
114
Inclusion Criteria

Those who are participants in the 2023 Iwaki Health Promotion Project Medical Checkup and meet the following inclusion criteria.
-Inclusin criteria-
1. Men and women who are 20 years old or over and under 75 years of age
2. Those with BMI of 23 kg/m2 or more
3. Those with visceral fat area of 80 cm2 or more

Exclusion Criteria

1. Those who with hepatic, renal, heart disease, respiratory disorders, digestive disorders, endocrine disorders, metabolic disorders, neuropathy, consciousness disorders, diabetes, hyperlipidemia, hypertension, or other diseases and who are receiving medication treatment and are judged to be inappropriate by a doctor.
2. Those who take diabetes medications such as alpha-glucosidase inhibitors or biguanides that may affect the gut microbiota.
3. Pregnant women (those who plan to become pregnant)
4. Those who work night shifts at least once a week
5. Those who have a history of gastrointestinal resection (excluding appendectomy)
6. Those who have positive HBs antigen markers
7. Those who have positive HCV antibody markers
8. Those who have food allergies
9. Those who are allergic to metal (stainless steel) or have a pacemaker in their body
10. Those who have a history of malignant tumors
11. Those who have a history of mental illness
12. Those who have changes more than 2 kg of weight within 3 months of the start of this study
13. Those who regularly use pharmaceuticals, etc. that may affect the present study
14. Those who donated 200 mL or more of blood within one month of the start of the study, or those who plan to do so during the research period.
15. Those who cannot measure with a visceral fat measuring device
16. Other persons who are judged inappropriate by the principal investigator or the co-investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath